IRMIRM
Subscribe to our Email Alerts
  •  

  • Menu
  • Home
  • About Us
    • Company Overview
    • Board of Directors
    • Management
    • Medical Advisors
    • Company Constitution
    • Corporate Governance
    • Privacy Policy
    • Working at Noxopharm
  • Pipeline
    • Our Technology
    • Clinical Overview
    • Clinical Studies
  • Investors
    • Welcome
    • Share Price Information
    • Share Registry
    • ASX Announcements
    • Financial Reports
    • Annual Reports
    • Half Yearly Reports
    • Quarterly Reports
    • Presentations
    • Analyst Reports
  • News
    • Media
    • Latest News
    • Presentations
    • Newsletters
    • Blog
    • Publications
  • Contact Us
    • Contact Us
    • Email Alerts
    • Careers

SIte Map

A company aiming to create a drug to treat cancer in an innovative way that we believe will bring significant change to the management of cancer.

> SIte Map >
Font Smaller Font larger Print Page

SIte Map

    SIte Map

    Home

    • Home
    • About Us
      • Company Overview
      • Board of Directors
      • Management
      • Medical Advisors
      • Company Constitution (All)
      • Corporate Governance (All)
      • Privacy Policy
      • Working at Noxopharm
    • Pipeline
      • Our Technology
      • Clinical Overview
      • Clinical Studies
    • Investors
      • Welcome
      • Share Price Information
      • Share Registry
      • ASX Announcements (All)
      • Financial Reports (All)
      • Annual Reports (All)
      • Half Yearly Reports (All)
      • Quarterly Reports  (All)
      • Presentations  (All)
      • Analyst Reports (All)
    • News
      • Media (All)
      • Latest News (All)
      • Presentations (All)
      • Newsletters (All)
      • Blog
      • Publications (All)
    • Contact Us
      • Contact Us
      • Email Alerts
      • Careers

    • Privacy

    Email Alerts

    To receive email responses and updates from Noxopharm Limited, simply fill in your details using the form below.

    Which of the following group do you best fit?

    Do you currently hold shares in this Company?

    Do not wish to receive further emails from Noxopharm Limited Click here to unsubscribe

    Quick Links

    • Investors
    • Latest News
    • Presentations
    • About Us
    • Media

    Location

    Address
    PO Box 824, Turramurra
    2074 NSW AUSTRALIA

    ABN
    50 608 966 123

    Contact us

    Email
    Shareholder enquiries: info@noxopharm.com
    Patient enquiries: medical.information@noxopharm.com

    Phone
    In Australia 02 9144 2223
    From Overseas +612 9144 2223

    Hong Kong Office:
    www.noxasialimited.com

    Read Our Latest Newsletter

    Join our mailing list to receive the latest information from Noxopharm Limited

    Copyright © Noxopharm | Privacy Statement | Site Map | Search
    Site by